Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1832-1834, 2000;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poon, L. L.M.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poon, L. L.M.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2000;46:1832-1834.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Presence of Fetal RNA in Maternal Plasma

Leo L.M. Poon1, Tse N. Leung2, Tze K. Lau2 and Y.M. Dennis Lo1,a

Departments of
1 Chemical Pathology and
2 Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR
a address correspondence to this author at: Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Room 38023, 1/F Clinical Sciences Building, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong SAR; fax 852-2194-6171, e-mail loym{at}cuhk.edu.hk


   Introduction
Top
 Introduction
References
 
The discovery of fetal DNA in maternal plasma (1) has opened up a new horizon on prenatal molecular diagnosis. Many groups have since shown that fetal genetic traits, such as RhD status and inherited genetic diseases, can be determined from fetal DNA in maternal plasma (2)(3)(4)(5). However, it is not known whether fetal RNA is also present in maternal plasma. Here, using a two-step reverse transcription (RT)-PCR assay, we demonstrate the presence of fetal-derived, male-specific mRNA in plasma of pregnant women carrying male fetuses.

Pregnant women attending the Prenatal Diagnosis Unit at the Department of Obstetrics and Gynecology, Prince of Wales Hospital, Hong Kong were recruited with informed consent. The study was approved by the Clinical Research Ethics Committee. Women early and late in their pregnancies (n = 21 and 37, respectively) were recruited in this study. The mean gestational ages of the subjects in early and late pregnancies were 16 weeks (range, 11–19 weeks) and 33 weeks (range, 26–40 weeks), respectively. All early-pregnancy samples were obtained before any invasive procedure. On the other hand, late-pregnancy samples were collected either from women who had invasive procedures in early pregnancy (n = 21) or from women who did not have any prenatal invasive procedure (n = 16). All plasma samples were harvested within 30 min from EDTA-blood samples as described previously (1). Total RNA from plasma samples was isolated with the Trizol LS Reagent (Life Technologies) as instructed by the manufacturer. In general, RNA isolated from 1 mL of plasma was dissolved in 50 µL of RNase-free water.

In this study, we chose to detect fetal-derived, Y-chromosome-specific zinc finger protein (ZFY) mRNA (6)(7) in maternal plasma. As shown in Fig. 1 , RT-PCR products corresponding to ZFY mRNA were observed only when male placental total RNA was used in the RT-PCR assay (Fig. 1 , lane 1). By contrast, no positive signal was detected when either reverse transcriptase was omitted (Fig. 1 , lane 2) or female placental total RNA was used (Fig. 1 , lane 3) in the RT-PCR assays. Among 20 women carrying male fetuses in late pregnancy, ZFY-positive signals were detected (Fig. 1 , middle panel, lanes 6–10) in 13 plasma samples. Positive signals were observed in two of nine women carrying male fetuses in early pregnancy. The identities of ZFY mRNA-specific RT-PCR products in the positive cases were confirmed by DNA sequencing (data not shown). By contrast, of 20 women carrying female fetuses either in early (n = 12) or in late (n = 8) pregnancy, all but 1 case were negative in the assay (Fig. 1 , middle panel, lanes 11–14). The only false-positive case was presumably attributable to contamination during RNA processing. As a control for the quality of the extracted RNA, we also subjected all samples to a RT-PCR assay for HLA-G mRNA (8). The HLA-G gene is expressed by both fetal [e.g., trophoblasts (8)] and maternal [e.g., lymphocytes (9)] tissues. As shown in the bottom panel of Fig. 1 , RT-PCR products specific for HLA-G mRNA were detected in all tested plasma samples, demonstrating the presence of amplifiable RNA in these samples.



View larger version (97K):
[in this window]
[in a new window]
  		Figure 1. Detection of fetal ZFY mRNA from maternal plasma.

Lane 1, positive control; lanes 2–5, negative controls as indicated; lanes 6–10, RNA isolated from women carrying male fetuses; lanes 11–14, RNA isolated from women carrying female fetuses; lane 14, water control. RT-PCR products of ZFY (89 bp) and HLA-G (246 bp) mRNA are indicated. M, DNA markers. To convert plasma RNA into cDNA, 10 µL of RNA dissolved in RNase-free water was primed with 100 ng of random primers and reverse-transcribed by Superscript RT II (Life Technologies) according to the manufacturer’s recommendations. The reverse-transcribed products were then amplified by AmpliTaq Gold DNA polymerase (PE Biosystems) as instructed by the manufacturer. To detect ZFY cDNA, a pair of intron-spanning primers specific for ZFY cDNA (forward primer, 5'-GACTACCTAATGATTTCGTTGGATG-3', corresponding to nucleotides 616–641 of ZFY cDNA; reverse primer, 5'-TCCATTTCTGATTCTGCATCG-3', complementary to nucleotides 704–684 of ZFY cDNA) was used in the PCR reactions (50 cycles of 95 °C for 1 min, 56 °C for 1 min, and 72 °C for 30 s). To detect HLA-G cDNA, a pair of intron-spanning primers, 5G2RNA and G3E3, were used in the PCR reaction as described (8).

Recently, it has been demonstrated that a proportion of maternal plasma fetal DNA circulates in the form of intact fetal cells (10). Thus, theoretically it is possible that the fetal RNA that we detected in the current study could have originated from these "plasma-derived" cells. To conclusively test whether fetal RNA can be detected in the "cell-free" form in maternal circulation, maternal plasma samples were filtered by a 0.2 µm membrane (Nalgene), and the RNA extracted from these filtered plasma samples was tested by the ZFY RT-PCR assay. Of nine filtered plasma samples collected from women carrying male fetuses in late pregnancies, positive ZFY mRNA signals were detected in six samples (data not shown). These results indicate that at least a portion of fetal RNA in maternal plasma exists in the cell-free form. This observation is consistent with the recent finding that tumor-derived RNA can be detected in the circulation of cancer patients (11)(12).

Our data demonstrate that fetal RNA can be detected in maternal plasma. The detection rates of plasma fetal RNA in early and late pregnancies were 22% and 63%, respectively. The detection rate of fetal RNA in early pregnancy cases was lower than that in late pregnancy cases, suggesting that the concentration of plasma fetal RNA is lower in early pregnancy. This observation is similar to our previous finding that the concentration of fetal DNA in maternal plasma increases with gestation (13). We also realized that the detection rate of plasma fetal RNA in this study is lower than that of plasma fetal DNA (1). It is possible that fetal RNA is more susceptible to degradation in maternal blood. As a result, the amount of fetal RNA in plasma is much lower than plasma fetal DNA. This is supported by the fact that Y-specific DNA was detected in all plasma samples from women carrying male fetuses in this study (data not shown). To improve the sensitivity of maternal plasma fetal RNA detection, we are now developing a highly sensitive real-time quantitative RT-PCR assay for this purpose.

In conclusion, we have shown for the first time that fetal RNA can be detected in maternal plasma, and our data provide a novel means of noninvasive prenatal diagnosis. Plasma fetal DNA analysis can provide data on the presence and concentration of fetal genetic material in the maternal circulation. Plasma fetal RNA analysis, in addition, can provide valuable information regarding the gene expression patterns of fetal tissues. For example, abnormal pregnancies, such as those with preeclampsia, often are associated with abnormal gene expression patterns in fetal tissues (14). Thus, with the development of further RNA markers, maternal plasma RNA analysis may allow the noninvasive monitoring of fetal gene expression in a multitude of physiological and pathological conditions.


   Acknowledgments
 
This work is supported by the Earmarked Research Grants Scheme from the Hong Kong Research Grants Council (CUHK 4255/99M) and a grant from the Industrial Support Fund (AF/90/99).


   References
Top
 Introduction
 References
 

  1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.[ISI][Medline] [Order article via Infotrieve]
  2. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.[Abstract/Free Full Text]
  3. Faas BHW, Beuling EA, Christiaens GCML, von dem Borne AEGK, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma [Letter]. Lancet 1998;352:1196.[ISI][Medline] [Order article via Infotrieve]
  4. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma [Technical Brief]. Clin Chem 2000;46:301-302.[Free Full Text]
  5. Chen CP, Chern SR, Wang W. Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy [Letter]. Prenat Diagn 2000;20:355-357.[ISI][Medline] [Order article via Infotrieve]
  6. Page DC, Mosher R, Simpson EM, Fisher EM, Mardon G, Pollack J, et al. The sex-determining region of the human Y chromosome encodes a finger protein. Cell 1987;51:1091-1104.[ISI][Medline] [Order article via Infotrieve]
  7. Palmer MS, Berta P, Sinclair AH, Pym B, Goodfellow PN. Comparison of human ZFY and ZFX transcripts. Proc Natl Acad Sci U S A 1990;87:1681-1685.[Abstract/Free Full Text]
  8. Hviid TVF, Møller C, Sørensen S, Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 1998;59:87-98.[ISI][Medline] [Order article via Infotrieve]
  9. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994;91:4209-4213.[Abstract/Free Full Text]
  10. van Wijk IJ, de Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MA, et al. Detection of apoptotic fetal cells in plasma of pregnant women [Technical Brief]. Clin Chem 2000;46:729-731.[Free Full Text]
  11. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999;5:1961-1965.[Abstract/Free Full Text]
  12. Lo KW, Lo YMD, Leung SF, Tsang YS, Chan LYS, Johnson PJ, et al. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma [Technical Brief]. Clin Chem 1999;45:1292-1294.[Free Full Text]
  13. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775.[ISI][Medline] [Order article via Infotrieve]
  14. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN, Jr, Bennett WA. Expression of the placental cytokines tumor necrosis factor {alpha}, interleukin 1 ß, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999;181:915-920.[ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Y. M. Dennis Lo and R. W. K. Chiu
Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidies by Maternal Plasma Nucleic Acid Analysis
Clin. Chem., March 1, 2008; 54(3): 461 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
S. Okazaki, A. Sekizawa, Y. Purwosunu, A. Farina, N. Wibowo, and T. Okai
Placenta-Derived, Cellular Messenger RNA Expression in the Maternal Blood of Preeclamptic Women
Obstet. Gynecol., November 1, 2007; 110(5): 1130 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Rani, M. Clynes, and L. O'Driscoll
Detection of Amplifiable mRNA Extracellular to Insulin-Producing Cells: Potential for Predicting Beta Cell Mass and Function
Clin. Chem., November 1, 2007; 53(11): 1936 - 1944.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Y. Purwosunu, A. Sekizawa, K. Koide, A. Farina, N. Wibowo, G. H. Wiknjosastro, S. Okazaki, H. Chiba, and T. Okai
Cell-Free mRNA Concentrations of Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator Are Increased in the Plasma of Pregnant Women with Preeclampsia
Clin. Chem., March 1, 2007; 53(3): 399 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. C.K. Wong, R. W.K. Chiu, N. B.Y. Tsui, K.C. A. Chan, L. W. Chan, T. K. Lau, T. N. Leung, and Y.M. D. Lo
Circulating Placental RNA in Maternal Plasma Is Associated with a Preponderance of 5' mRNA Fragments: Implications for Noninvasive Prenatal Diagnosis and Monitoring
Clin. Chem., October 1, 2005; 51(10): 1786 - 1795.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. B. Larrabee, K. L. Johnson, I. Peter, and D. W. Bianchi
Presence of Filterable and Nonfilterable Cell-Free mRNA in Amniotic Fluid
Clin. Chem., June 1, 2005; 51(6): 1024 - 1026.
[Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
Y.M. D. Lo
Recent Advances in Fetal Nucleic Acids in Maternal Plasma
J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. R. Gingeras, R. Higuchi, L. J. Kricka, Y.M. D. Lo, and C. T. Wittwer
Fifty Years of Molecular (DNA/RNA) Diagnostics
Clin. Chem., March 1, 2005; 51(3): 661 - 671.
[Full Text] [PDF]

Home page
 JAMAHome page
P. B. Larrabee, K. L. Johnson, C. Lai, J. Ordovas, J. M. Cowan, U. Tantravahi, and D. W. Bianchi
Global Gene Expression Analysis of the Living Human Fetus Using Cell-Free Messenger RNA in Amniotic Fluid
JAMA, February 16, 2005; 293(7): 836 - 842.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
F. Z. Bischoff, D. E. Lewis, and J. L. Simpson
Cell-free fetal DNA in maternal blood: kinetics, source and structure
Hum. Reprod. Update, January 1, 2005; 11(1): 59 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. K. Gupta, W. Holzgreve, B. Huppertz, A. Malek, H. Schneider, and S. Hahn
Detection of Fetal DNA and RNA in Placenta-Derived Syncytiotrophoblast Microparticles Generated in Vitro
Clin. Chem., November 1, 2004; 50(11): 2187 - 2190.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. K.O. Ng, A. El-Sheikhah, R. W.K. Chiu, K.C. A. Chan, M. Hogg, R. Bindra, T. N. Leung, T. K. Lau, K. H. Nicolaides, and Y.M. D. Lo
Evaluation of Human Chorionic Gonadotropin {beta}-Subunit mRNA Concentrations in Maternal Serum in Aneuploid Pregnancies: A Feasibility Study
Clin. Chem., June 1, 2004; 50(6): 1055 - 1057.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
N B Y Tsui, S S C Chim, R W K Chiu, T K Lau, E K O Ng, T N Leung, Y K Tong, K C A Chan, and Y M D Lo
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling
J. Med. Genet., June 1, 2004; 41(6): 461 - 467.
[Full Text] [PDF]

Home page
 Reproductive SciencesHome page
K. A. Dukes, L. M. Sullivan, D. Lewis, K. L. Johnson, D. W. Bianchi, J. L. Simpson, W. Holzgreve, S. Hahn, F. Z. Bischoff, and L. G. Jackson
The Effect of the Elapsed Time Between Blood Draw and Processing on the Recovery of Fetal Cells From Maternal Blood
Reproductive Sciences, April 1, 2004; 11(3): 154 - 165.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
C. B.M. Oudejans, A. T.J.J. Go, A. Visser, M. A.M. Mulders, B. A. Westerman, M. A. Blankenstein, and J. M.G. van Vugt
Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma
Clin. Chem., September 1, 2003; 49(9): 1445 - 1449.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J.-M. Costa, A. Benachi, M. Olivi, Y. Dumez, M. Vidaud, and E. Gautier
Fetal Expressed Gene Analysis in Maternal Blood: A New Tool for Noninvasive Study of the Fetus
Clin. Chem., June 1, 2003; 49(6): 981 - 983.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. W.K. Chiu, L. Y.S. Chan, N. Y.L. Lam, N. B.Y. Tsui, E. K.O. Ng, T. H. Rainer, and Y.M. D. Lo
Quantitative Analysis of Circulating Mitochondrial DNA in Plasma
Clin. Chem., May 1, 2003; 49(5): 719 - 726.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. K.O. Ng, T. N. Leung, N. B.Y. Tsui, T. K. Lau, N. S. Panesar, R. W.K. Chiu, and Y.M. D. Lo
The Concentration of Circulating Corticotropin-releasing Hormone mRNA in Maternal Plasma Is Increased in Preeclampsia
Clin. Chem., May 1, 2003; 49(5): 727 - 731.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. A. Ferguson-Smith
Placental mRNA in maternal plasma: Prospects for fetal screening
PNAS, April 15, 2003; 100(8): 4360 - 4362.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. K. O. Ng, N. B. Y. Tsui, T. K. Lau, T. N. Leung, R. W. K. Chiu, N. S. Panesar, L. C. W. Lit, K.-W. Chan, and Y. M. D. Lo
From the Cover: mRNA of placental origin is readily detectable in maternal plasma
PNAS, April 15, 2003; 100(8): 4748 - 4753.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. V. Hviid
In-Cell PCR Method for Specific Genotyping of Genomic DNA from One Individual in a Mixture of Cells from Two Individuals: A Model Study with Specific Relevance to Prenatal Diagnosis Based on Fetal Cells in Maternal Blood
Clin. Chem., December 1, 2002; 48(12): 2115 - 2123.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. B.Y. Tsui, E. K.O. Ng, and Y.M. D. Lo
Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma
Clin. Chem., October 1, 2002; 48(10): 1647 - 1653.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. K.O. Ng, N. B.Y. Tsui, N. Y.L. Lam, R. W.K. Chiu, S. C.H. Yu, S.C. C. Wong, E. S.F. Lo, T. H. Rainer, P. J. Johnson, and Y.M. D. Lo
Presence of Filterable and Nonfilterable mRNA in the Plasma of Cancer Patients and Healthy Individuals
Clin. Chem., August 1, 2002; 48(8): 1212 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
B. Pertl and D. W. Bianchi
Fetal DNA in Maternal Plasma: Emerging Clinical Applications
Obstet. Gynecol., September 1, 2001; 98(3): 483 - 490.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poon, L. L.M.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poon, L. L.M.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS